PL DEVELOPMENTS — Nicotine Importer Profile
Pharmaceutical Importer · #1 buyer for Nicotine · $3.7M import value · 94 shipments · UNITED STATES · DGFT Verified
PL DEVELOPMENTS is the #1 importer of Nicotine from India with $3.7M in import value and 94 verified shipments. PL DEVELOPMENTS holds a 31.5% market share in Nicotine imports based in UNITED STATES. The company sources from 1 verified supplier across 32 formulations shipped to 1 country. Overall, PL DEVELOPMENTS imports 7 pharmaceutical products worth $18.3M across 6 therapeutic categories.
PL DEVELOPMENTS — Nicotine Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Nicotine to PL DEVELOPMENTS?
Verified from 94 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| RUBICON RESEARCH PRIVATE LIMITED | $3.7M | 94 | 100.0% |
PL DEVELOPMENTS sources Nicotine from 1 verified Indian supplier based on 94 customs records. The primary supplier is RUBICON RESEARCH PRIVATE LIMITED accounting for 100.0% of imports.
How Does PL DEVELOPMENTS Compare to Nearest Nicotine Importers?
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | PL DEVELOPMENTS ★ | UNITED STATES | $4.7M | 94 | $50.0K |
| 3 | HASSAN ALI BIN SALMAN LAGHA TRADIN | SAUDI ARABIA | $137.9K | 12 | $11.5K |
| 4 | DINESH KUMAR GENERAL TRADING LLC | UNITED ARAB EMIRATES | $105.0K | 3 | $35.0K |
PL DEVELOPMENTS ranks #1 among 100 Nicotine importers from India. Average shipment value of $50.0K compared to the market average of $56.0K. The closest competitors by value are HASSAN ALI BIN SALMAN LAGHA TRADIN and DINESH KUMAR GENERAL TRADING LLC.
Where Does PL DEVELOPMENTS Import Nicotine To?
Destination countries from 94 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $3.7M | 94 | 100.0% |
PL DEVELOPMENTS imports Nicotine to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $3.7M.
What Nicotine Formulations Does PL DEVELOPMENTS Import?
| Formulation | Value | Shipments |
|---|---|---|
| NICOTINE POL MINI LOZ 4MG 20000 CHERRY P | $563.6K | 15 |
| NICOTINE POL LOZ 2MG 4000 CHERRY PLD [NI | $500.0K | 10 |
| 40085 Nicotine Pol Loz 4mg 4000 Cherry P | $250.0K | 5 |
| 40095 Nicotine Pol Loz 4mg 4000 Cin'mon | $203.2K | 5 |
| 40079 NicotinePol Mini Loz 4mg 20000 Che | $155.3K | 4 |
| 40082 Nicotine Pol Loz 2mg 4000 Cherry P | $152.1K | 4 |
| 40065 Nicotine Pol Loz 4mg 4000 Mint PLD | $150.0K | 3 |
| Nicotine Pol Loz 4mg 4000 MINT PLD 40823 | $150.0K | 3 |
| Nicotine Pol Loz 2mg 4000 Mint PLD- 4082 | $150.0K | 3 |
| Nicotine Pol Loz 2mg 4000 Cin'mon PLD 4 | $150.0K | 3 |
PL DEVELOPMENTS imports 32 distinct Nicotine formulations from India. The top formulation is NICOTINE POL MINI LOZ 4MG 20000 CHERRY P with 15 shipments worth $563.6K.
Regulatory Requirements: Importing Nicotine into United States
What PL DEVELOPMENTS and other importers must comply with to import Nicotine from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Nicotine
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Nicotine from India and How Much Does PL DEVELOPMENTS Import?
India exported $5.6M worth of Nicotine through 837 shipments from 61 suppliers to 34 countries, serving 100 buyers globally. PL DEVELOPMENTS imports $3.7M of this total, accounting for 31.5% of India's Nicotine exports with 94 shipments from UNITED STATES. This is verified from 94 customs shipment records covering 32 distinct formulations.
What Is the Average Order Value for PL DEVELOPMENTS's Nicotine Imports?
PL DEVELOPMENTS's average Nicotine order value is $39.6K per consignment, based on 94 shipments totaling $3.7M. PL DEVELOPMENTS is based in UNITED STATES and ranks #1 among all Nicotine importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Nicotine to PL DEVELOPMENTS?
PL DEVELOPMENTS sources Nicotine from 1 verified Indian supplier: RUBICON RESEARCH PRIVATE LIMITED ($3.7M, 100.0%). This is based on 94 customs records.
How Does PL DEVELOPMENTS Compare to Other Nicotine Importers?
PL DEVELOPMENTS ranks #1 among 100 Nicotine importers from India with a 31.5% market share. The top 3 importers are PL DEVELOPMENTS ($4.7M), HASSAN ALI BIN SALMAN LAGHA TRADIN ($137.9K), DINESH KUMAR GENERAL TRADING LLC ($105.0K). PL DEVELOPMENTS processed 94 shipments from UNITED STATES.
About PL DEVELOPMENTS
PL DEVELOPMENTS imports 7 products worth $18.3M. Beyond Nicotine, top products include Docusate, Miconazole, Diphenhydramine, Clotrimazole, Aspirin. View the complete PL DEVELOPMENTS profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Nicotine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Nicotine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: PL DEVELOPMENTS matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as PL DEVELOPMENTS's capped import value divided by total capped export value for Nicotine across all Indian exporters.
- 5.Verified Records: This page is backed by 94 individual customs records matching PL DEVELOPMENTS importing Nicotine, covering 32 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 34+ countries, 100+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Nicotine Import Data for PL DEVELOPMENTS
Access order-level details, pricing data, supplier connections, and competitive analysis for PL DEVELOPMENTS's Nicotine imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
PL DEVELOPMENTS
Full Company Profile →
7 products · $18.3M total trade · 6 categories
PL DEVELOPMENTS × Nicotine
Verified from customs records
Company Overview
Top Products by PL DEVELOPMENTS
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for PL DEVELOPMENTS.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Nicotine. For current order-level data, contact TransData Nexus.